FDA welcomes the National Audit Office report on Ofsted
The FDA has welcomed the National Audit Office report on Ofsted, which highlights a number of issues which the union has been raising with its meetings with the department. This includes the effect the 40% decrease in budget over the past decade has had on staff numbers while responsibilities have increased as it moves its remit into new sectors.
It also highlights the point that whilst the number of key targets have been missed, the quality of inspections has increased, which is a demonstration of the hard work of HM Inspectors (HMIs).
Jawad Raza, FDA National Officer for Ofsted, said: “We welcome Ofsted’s assurance that it is looking at a number of these issues, however, now is the time for action. Our members are working longer hours than ever to keep the quality of inspections at the level they are at and that is a testament to the commitment and dedication of HMIs, but goodwill can only last for so long. Ofsted also needs to address the recruitment and retention issues, including pay, which will help to attract new inspectors, increase staff numbers and help to reduce the workload of our members.”
The full report is available here.
It also highlights the point that whilst the number of key targets have been missed, the quality of inspections has increased, which is a demonstration of the hard work of HM Inspectors (HMIs).
Jawad Raza, FDA National Officer for Ofsted, said: “We welcome Ofsted’s assurance that it is looking at a number of these issues, however, now is the time for action. Our members are working longer hours than ever to keep the quality of inspections at the level they are at and that is a testament to the commitment and dedication of HMIs, but goodwill can only last for so long. Ofsted also needs to address the recruitment and retention issues, including pay, which will help to attract new inspectors, increase staff numbers and help to reduce the workload of our members.”
The full report is available here.
Related News
-
“An outstanding leader with a proven track record” – FDA responds to Dame Antonia Romeo appointment
The FDA has welcomed the appointment of former Home Office Permanent Secretary Dame Antonia Romeo as Cabinet Secretary, following the departure of Sir Chris Wormald last week.
-
“New low” for government’s relationship with civil service – FDA responds following departure of Cabinet Secretary Chris Wormald
The FDA has responded to the announcement that Sir Chris Wormald has departed the role of Cabinet Secretary, with FDA General Secretary Dave Penman describing it as a “new low” for the government’s relationship with the civil service.
-
“Farcical” to wait until 2030 to make decision on restoration and renewal of parliament, says FDA
The FDA has responded to the latest publication of UK Parliament’s Restoration and Renewal Board, ‘Delivering restoration and renewal of the Palace of Westminster: the costed proposals.’
